Agitated Depression and the Potential Response to Gama-Amino Butyric Acid Agonist: A Case Series and Literature Review

Keyphrases

• Potential Response 100%
• Agitated Depression 100%
• Depressive Disorder 80%
• Antidepressants 60%
• Antipsychotics 40%
• Electroconvulsive Therapy 40%
• Lithium 20%
• Depressive Symptoms 20%
• Psychosis 20%
• Poor Appetite 20%
• Psychiatry 20%
• Proper Treatment 20%
• Review Literature 20%
• Poor Sleep 20%
• Suicide Risk 20%
• Lack of Response 20%
• Agonist Treatment 20%
• Lorazepam 20%
• Benzodiazepines 20%
• Poor Response 20%
• Depressed Mood 20%
• Depression Treatment 20%
• Olanzapine 20%
• Insomnia 20%
• Rumination 20%
• γ-aminobutyric Acid 20%
• Anticonvulsant 20%
• Antidepressant Efficacy 20%
• Melancholia 20%
• Indecisiveness 20%
• Psychomotor Agitation 20%

Neuroscience

• Agonist 100%
• Gamma-Aminobutyric Acid 100%
• Aminobutyric Acid Derivative 100%
• Antidepressant 80%
• Depressive Disorder 80%
• Electroconvulsive Therapy 40%
• Psychiatry 20%
• Olanzapine 20%
• Melancholic Depression 20%
• Anticonvulsant 20%
• Lorazepam 20%

Pharmacology, Toxicology and Pharmaceutical Science

• 4 Aminobutyric Acid 100%
• Aminobutyric Acid Derivative 100%
• Antidepressant 80%
• Depressive Disorder 80%
• Restlessness 60%
• Olanzapine 20%
• Anticonvulsive Agent 20%
• Lorazepam 20%
• 4 Aminobutyric Acid Receptor Stimulating Agent 20%
• Melancholia 20%